Christopher Kuc, OD
Optometrist · Lexington, KYNPI 1073513412
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $34,142 of the $51,943 with a category attached, or 65.7%. Bausch & Lomb Americas Inc. accounts for 76.9% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $38,910, more than ten times the $2,635 reported in 2019. Among optometrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $165.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$40K
- Alcon$2K
- Tarsus Pharmaceuticals, Inc.$2K
- Sun Pharmaceutical Industries Inc.$1K
- Carl Zeiss Meditec, Inc.$984
- AbbVie$684
- plus $6K from 25 others
Across 20 payments — averaging $45.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$900
What the payments were for
- Consulting fees$2,2104%
- Speaking & faculty fees$34,14266%
- Travel & lodging$3,7127%
- Food & beverage$11,87823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 87 | $39,930 |
| Alcon | 26 | $1,694 |
| Tarsus Pharmaceuticals, Inc. | 15 | $1,671 |
| Sun Pharmaceutical Industries Inc. | 35 | $1,270 |
| Carl Zeiss Meditec, Inc. | 5 | $984 |
| AbbVie(2 entities) | 14 | $684 |
| Novartis | 24 | $596 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $590 |
| Oyster Point Pharma, Inc. | 15 | $509 |
| Biotissue Holdings Inc. | 9 | $476 |
| LKC Technologies, Inc. | 5 | $443 |
| Dompe US, Inc. | 9 | $409 |
| Harrow Eye, LLC | 7 | $357 |
| Carl Zeiss Meditec USA, Inc. | 1 | $350 |
| Rxsight Inc | 6 | $326 |
| Johnson & Johnson Vision Care, Inc. | 6 | $319 |
| Shire North American Group Inc | 5 | $314 |
| Kala Pharmaceuticals, Inc. | 6 | $231 |
| Coopervision Inc. | 5 | $210 |
| Quidel Corporation | 3 | $151 |
| Amgen | 2 | $96 |
| Visioneering Technologies, Inc. | 3 | $94 |
| Thea Pharma Inc. | 3 | $46 |
| Topcon Healthcare, Inc. | 1 | $37 |
| Tearlab Corp | 2 | $34 |
| ABB Con-cise Optical Group LLC | 2 | $30 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $25 |
| Sight Sciences, Inc. | 1 | $22 |
| Notal Vision, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIIDRA$38,070
- MIEBO$37,973
- DAILIES$1,078
- XDEMVY$1,038
- CIRRUS HD-OCT$810
- CEQUA$758
- FORUM$730
- AIR OPTIX$644
- CLARUS$580
- ATLAS 500$580
- CIRRUS 6000 with AngioPlex$350
- TYRVAYA$247
- VEVYE$247
- Humphrey Field Analyzer (HFA3)$230
- Humphrey HFA$230
- IOLMaster 700$230
- VERACITY SURGICAL$230
- VisuMax$230
- RXSIGHT CONTACT LENS$226
- RXSIGHT INJECTOR CARTRIDGE$226
How this compares
$51,943 in reported general payments places this provider in the 95th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 22 | $16,647 |
| LumiganBimatoprost | 16 | $9,553 |
| Cyclosporine | 20 | $9,275 |
| VyzultaLatanoprostene Bunod | 16 | $5,476 |
| Loteprednol Etabonate | 28 | $4,746 |
| Fluorometholone | 19 | $1,847 |
| Latanoprost | 60 | $896 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 34 | $477 |
| Timolol Maleate | 34 | $260 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $183 |
| Doxycycline Hyclate | 13 | $101 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $684 | $26,20038 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $39,930 | $5,47616 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $590 | $4,74628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 712 optometrist providers in Kentucky.
Other optometrist in Lexington
- Paul KarpeckiLexington$3.6M
- Bilal AhmadLexington$150K
- Joe McMillinLexington$11K
- Karen McMillinLexington$10K
- Tania PatelLexington$6K
- Danielle FrankLexington$5K
- Ashley LaneLexington$5K
- Steven SpearLexington$5K
- Howell FindleyLexington$5K
- Lisa WangLexington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.